Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1995;76:720-725

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morano, I.
Right arrow Articles by Michel, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morano, I.
Right arrow Articles by Michel, G.
(Circulation Research. 1995;76:720-725.)
© 1995 American Heart Association, Inc.


Articles

Myosin Light Chain–Actin Interaction Regulates Cardiac Contractility

Ingo Morano, Oliver Ritter, Andreas Bonz, Tomasz Timek, Christian F. Vahl, Gerd Michel

From the Max-Delbrück-Center for Molecular Medicine (I.M.), Berlin; the Department for Physiology II (O.R.) and Department of Cardiac Surgery (A.B., T.T., C.F.V.), University of Heidelberg; and Abbott Laboratories (G.M.), European Research, Wiesbaden, Germany.

Correspondence to Dr I. Morano, Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str 10, 13122 Berlin, Germany.

Abstract The amino-terminal domain of the essential myosin light chain (MLC-1) binds to the carboxy terminus of the actin molecule. We studied the functional role of this interaction by two approaches: first, incubation of intact and chemically skinned human heart fibers with synthetic peptide corresponding to the sequences 5 through 14 (P5-14), 5 through 8 (P5-8), and 5 through 10 (P5-10) of the human ventricular MLC-1 (VLC-1) to saturate actin-binding sites, and second, incubation of skinned human heart fibers with a monoclonal antibody (MabVLC-1) raised against the actin-interacting N-terminal domain of human VLC-1 using P5-14 as antigen to deteriorate VLC-1 binding to actin. P5-14 increased isometric tension generation of skinned human heart fibers at both submaximal and maximal Ca2+ activation, the maximal effective peptide dosage being in the nanomolar range. A scrambled peptide of P5-14 with random sequence had no effects up to 10-8 mol/L, ie, where P5-14 was maximally effective. P5-8 and P5-10 increased isometric force to the same extent as P5-14, but micromolar concentrations were required. Amplitude of isometric twitch contraction, rate of tension development, rate of relaxation, and shortening velocity at near-zero load of electrically driven intact human atrial fibers increased significantly on incubation with P5-14. These alterations were not associated with modulation of intracellular Ca2+ transients as monitored by fura 2 fluorescence measurements. Incubation of skinned human heart fibers with MabVLC-1 increased isometric tension at both submaximal and maximal Ca2+ activation levels, having a maximal effective concentration in the femtomolar range. We conclude that VLC-1–actin interaction modulates cardiac contractility and may be a target for new inotropic intervention.


Key Words: human heart • skinned fiber • myosin light chain • calcium transient • fura 2




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden
Sarcomeric dysfunction in heart failure
Cardiovasc Res, March 1, 2008; 77(4): 649 - 658.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. Yan, B. M. Barnes, F. Kohl, and T. G. Marr
Modulation of gene expression in hibernating arctic ground squirrels
Physiol Genomics, January 17, 2008; 32(2): 170 - 181.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. M. Hernandez, M. Jones, G. Guzman, and D. Szczesna-Cordary
Myosin essential light chain in health and disease
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1643 - H1654.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. Haase, G. Dobbernack, G. Tunnemann, P. Karczewski, C. Cardoso, D. Petzhold, W.-P. Schlegel, S. Lutter, P. Pierschalek, J. Behlke, et al.
Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats
FASEB J, May 1, 2006; 20(7): 865 - 873.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
O. Andruchov, O. Andruchova, Y. Wang, and S. Galler
Dependence of cross-bridge kinetics on myosin light chain isoforms in rabbit and rat skeletal muscle fibres
J. Physiol., February 15, 2006; 571(1): 231 - 242.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
K. M. Brauch, N. D. Dhruv, E. A. Hanse, and M. T. Andrews
Digital transcriptome analysis indicates adaptive mechanisms in the heart of a hibernating mammal
Physiol Genomics, October 17, 2005; 23(2): 227 - 234.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Miller, B. M. Palmer, S. Ruch, L. A. Martin, G. P. Farman, Y. Wang, J. Robbins, T. C. Irving, and D. W. Maughan
The Essential Light Chain N-terminal Extension Alters Force and Fiber Kinetics in Mouse Cardiac Muscle
J. Biol. Chem., October 14, 2005; 280(41): 34427 - 34434.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Sugiura
Actin--myosin interaction
Cardiovasc Res, November 1, 1999; 44(2): 266 - 273.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Kameyama, Z. Chen, S. P. Bell, P. VanBuren, D. Maughan, and M. M. LeWinter
Mechanoenergetic Alterations During the Transition From Cardiac Hypertrophy to Failure in Dahl Salt-Sensitive Rats
Circulation, December 22, 1998; 98(25): 2919 - 2929.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Timek, C.-F. Vahl, A. Bonz, L. Schaffer, M. Rosenberg, and S. Hagl
Triiodothyronine reverses depressed contractile performance after excessive catecholamine stimulation
Ann. Thorac. Surg., November 1, 1998; 66(5): 1618 - 1625.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Bonne, L. Carrier, P. Richard, B. Hainque, and K. Schwartz
Familial Hypertrophic Cardiomyopathy : From Mutations to Functional Defects
Circ. Res., September 21, 1998; 83(6): 580 - 593.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. J. Solaro and H. M. Rarick
Troponin and Tropomyosin : Proteins That Switch on and Tune in the Activity of Cardiac Myofilaments
Circ. Res., September 7, 1998; 83(5): 471 - 480.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. P de Tombe
Altered contractile function in heart failure
Cardiovasc Res, February 1, 1998; 37(2): 367 - 380.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. C. Schaub, M. A. Hefti, R. A. Zuellig, and I. Morano
Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms
Cardiovasc Res, February 1, 1998; 37(2): 381 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. M. Rarick, T. J. Opgenorth, T. W. von Geldern, J. R. Wu-Wong, and R. J. Solaro
An Essential Myosin Light Chain Peptide Induces Supramaximal Stimulation of Cardiac Myofibrillar ATPase Activity
J. Biol. Chem., October 25, 1996; 271(43): 27039 - 27043.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sanbe, J. Gulick, J. Fewell, and J. Robbins
Examining the in Vivo Role of the Amino Terminus of the Essential Myosin Light Chain
J. Biol. Chem., August 24, 2001; 276(35): 32682 - 32686.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. K. Arrell, I. Neverova, H. Fraser, E. Marban, and J. E. Van Eyk
Proteomic Analysis of Pharmacologically Preconditioned Cardiomyocytes Reveals Novel Phosphorylation of Myosin Light Chain 1
Circ. Res., September 14, 2001; 89(6): 480 - 487.
[Abstract] [Full Text] [PDF]